Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Multinational trial assesses efficacy and safety of tolterodine for incontinence

June 9, 1997

Tamsulosin cleared by FDA

May 27, 1997

Mouse model for idiopathic voiding disorders in humans

May 15, 1997

Endothelin antagonists described by Takeda

May 14, 1997

Preclinical and clinical profile of Pharmacia & Upjohn's tolterodine

May 5, 1997

Inhibitors of 5alpha-reductase from Pharmacia & Upjohn

May 5, 1997

Synsorb Biotech recieves U.S. patent for the use of Synsorb Pk

April 24, 1997

IVAX presents promising preclinical results with Elmiron

April 22, 1997

Capsaicin for neurogenic bladder dysfunction and interstitial cystitis

April 17, 1997

New bladder-selective M3 antagonist reported by Yamanouchi

April 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...